Seymore Kayla D, Smitheman Hayley Powell, Smith Andy K, Pohlig Ryan T, Couppé Christian, Silbernagel Karin Grävare
Department of Physical Therapy, University of Delaware, Newark, Delaware, USA.
Department of Epidemiology, University of Delaware, Newark, Delaware, USA.
J Orthop Res. 2025 Apr;43(4):728-738. doi: 10.1002/jor.26038. Epub 2025 Jan 6.
A high proportion of individuals with Achilles tendinopathy continue to demonstrate long-term symptoms and functional impairments after exercise treatment. Thus, there is a need to delineate patient presentations that may require alternative treatment. The objective of this study was to evaluate if the presence of metabolic risk factors relates to tendon symptoms, psychological factors, triceps surae structure, and lower limb function in individuals with Achilles tendinopathy. One hundred and fifty-eight individuals (88 female) with diagnosed midportion Achilles tendinopathy were divided into three groups based on the number of metabolic risk factors linked to cardiovascular disease present at baseline: two or more factors, one factor, no factors. Metabolic risk factors were determined by clinical evaluation and past medical history. Achilles tendinopathy symptoms (Victorian Institute of Sport Assessment-Achilles, Patient Reported Outcome Measurement Information System, movement-evoked pain ratings), psychological factors (Tampa Scale for Kinesiophobia), triceps surae structure (B-mode ultrasound of tendon and muscle morphology, continuous shear wave elastography of tendon mechanical properties), and lower limb function (test battery) were compared among groups. Individuals with two or more metabolic risk factors had worse symptoms with loading (p = 0.011), smaller Achilles tendon size relative to body mass (p = 0.002), and worse lower limb function compared to individuals without metabolic risk factors (p < 0.02). No differences were observed between individuals with one metabolic risk factor and those without metabolic risk factors. Future consideration of multiple metabolic risk factors for individuals with Achilles tendinopathy could facilitate understanding the underlying impairments of tendon pathology and recovery that may be addressed with treatment.
相当比例的跟腱病患者在接受运动治疗后仍长期存在症状和功能障碍。因此,有必要明确可能需要替代治疗的患者表现。本研究的目的是评估代谢风险因素的存在是否与跟腱病患者的肌腱症状、心理因素、小腿三头肌结构和下肢功能有关。158名被诊断为跟腱中部病变的患者(88名女性)根据基线时存在的与心血管疾病相关的代谢风险因素数量分为三组:两个或更多因素、一个因素、无因素。代谢风险因素通过临床评估和既往病史确定。对三组患者的跟腱病症状(维多利亚运动评估-跟腱、患者报告结局测量信息系统、运动诱发疼痛评分)、心理因素(运动恐惧坦帕量表)、小腿三头肌结构(肌腱和肌肉形态的B型超声、肌腱力学性能的连续剪切波弹性成像)和下肢功能(测试组)进行比较。与无代谢风险因素的个体相比,有两个或更多代谢风险因素的个体在负重时症状更严重(p = 0.011),跟腱大小相对于体重更小(p = 0.002),下肢功能更差(p < 0.02)。有一个代谢风险因素的个体与无代谢风险因素的个体之间未观察到差异。未来对跟腱病患者多种代谢风险因素的考虑可能有助于理解肌腱病理和恢复的潜在损伤,而这些损伤可能通过治疗得到解决。